18 March 2021 2 Min Read
State-backed Biovac clinches deal with ImmunityBio to make Covid-19 vaccines
If the phase 1 trial demonstrates the vaccine elicits a response, larger phase 2 and 3 trials will be conducted during the year
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In